Related Experiment Video
Updated: May 23, 2026
07:30
Cell-cell Fusion of Genome Edited Cell Lines for Perturbation of Cellular Structure and Function
Published on: December 7, 2019
Implications of Heterotypic Cell Fusion in Cancer
Kathryn L Fowler1, Ashley N Anderson2, Taelor J Ekstrom2
1Department of Surgery, Oregon Health & Science University (OHSU), Portland, OR, USA.
Advances in Experimental Medicine and Biology
|May 21, 2026
Summary
Newly discovered hybrid cells, formed by cancer and immune cell fusion, drive cancer metastasis and treatment resistance. These circulating hybrid cells (CHCs) show promise as biomarkers for early detection and patient care.
Area of Science:
- Oncology
- Cell Biology
- Immunology
Background:
- Tumor microenvironment interactions are crucial for cancer evolution and patient outcomes.
- A novel neoplastic cell type arises from the fusion of neoplastic and immune cells, playing a key role in metastasis.
Purpose of the Study:
- To review the emerging field of tumor hybrid cells in cancer biology.
- To highlight the role of these cells in tumorigenesis, metastasis, and treatment resistance.
- To discuss the potential of circulating hybrid cells (CHCs) as biomarkers.
Main Methods:
- Review of existing literature on tumor-immune cell fusion.
- Analysis of hybrid cell characteristics and detection methods.
- Evaluation of clinical utility of CHCs.
Main Results:
- Hybrid cells, often from tumor-macrophage fusion, exhibit unique features and promote metastatic spread.
- These cells are found throughout the metastatic cascade: primary tumors, blood, and metastatic sites.
- Disseminated tumor-immune hybrids (CHCs) in peripheral blood have demonstrated clinical utility.
Conclusions:
- Tumor hybrid cells represent a significant advancement in understanding cancer biology.
- CHCs are valuable biomarkers for early cancer detection, risk stratification, and monitoring disease progression and treatment resistance.
- Further research into tumor hybrid cells can enhance cancer patient care and survival metrics.
Related Concept Videos
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
02:18Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
02:40Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
01:06Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...